Autonomix prices 4.5M shares at $1.11 in private placement

Autonomix (AMIX) Medical entered into a securities purchase agreement with a single institutional investor to purchase 4,501,666 shares of common stock and together with unregistered Series C warrants to purchase up to an aggregate 9,003,332 shares of common stock, in a private placement priced at the market under Nasdaq rules. The combined effective offering price for each share of common stock and accompanying Series C warrant is $1.1107. The Series C warrants will have an exercise price of $0.8607 per share, will be exercisable immediately, and will expire on the five and one-half year anniversary from the date of issuance. The gross proceeds to the Company from the Offering are estimated to be approximately $5.0 million before deducting the placement agent’s fees and other estimated Offering expenses. The Offering is expected to close on or about November 19, 2025, subject to the satisfaction of customary closing conditions. Maxim Group is acting as the sole placement agent in connection with the Offering.